EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure

Evelina Charidemou iD, Kyriacos Felekkis iD, Christos Papaneophytou iD

Biomolecules · 19.08.2025 · 15 (8) · 1189

DOI: 10.3390/biom15081189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 19.08.2025. Verfasst von Evelina Charidemou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Heart Failure, MicroRNAs, Natriuretic Peptides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a leading cause of morbidity and mortality worldwide, underscoring the need for improved diagnostic, prognostic, and therapeutic strategies. Circulating microRNAs (c-miRNAs) have emerged as promising non-invasive biomarkers due to their stability, tissue specificity, and regulatory roles in cardiac pathophysiology. This review highlights the potential of c-miRNAs in enhancing HF diagnosis, risk stratification, and therapeutic monitoring, particularly when integrated with conventional biomarkers such as natriuretic peptides, galectin-3, soluble ST2, and high-sensitivity troponins. We explore the roles of key miRNAs in HF pathogenesis—including cardiac hypertrophy, fibrosis, inflammation, apoptosis, and vascular remodeling—and discuss their diagnostic and prognostic significance. The potential of multi-analyte liquid biopsy approaches that combine c-miRNAs with protein biomarkers is also examined within the context of precision medicine. Despite promising data, challenges related to standardization, assay variability, and clinical validation remain. Addressing these gaps through harmonized protocols and large-scale studies will be essential for translating c-miRNAs into routine HF management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMicroRNAsNatriuretic PeptidesHumansLiquid BiopsyBiomarkersPrognosis

Stichwörter der Autor:innen

circulating microRNAsheart failuremultianalyte liquid biopsynatriuretic peptidesstratification

Substanzen

MicroRNAsBiomarkersNatriuretic Peptides

Autor:innen und Institutionen

  • Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.
  • Non-Coding RNA Research Laboratory, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.

ORCID-Profile: Evelina Charidemou, Kyriacos Felekkis, Christos Papaneophytou

Zitieren

APA

Charidemou, E., Felekkis, K., & Papaneophytou, C. (2025). From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure. Biomolecules, 15(8), 1189. https://doi.org/10.3390/biom15081189

Vancouver

Charidemou E, Felekkis K, Papaneophytou C. From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure. Biomolecules. 2025;15(8):1189. doi:10.3390/biom15081189

BibTeX
@article{Charidemou2025,
  author = {Charidemou, Evelina and Felekkis, Kyriacos and Papaneophytou, Christos},
  title = {From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {8},
  pages = {1189},
  doi = {10.3390/biom15081189}
}
Kostenlos starten →